Sotera Health Co (SHC)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $4.74B
Last updated: Nov 17, 2026 at 11:06 AM ET
Sotera Health Co (SHC) Financials: Revenue, Profit and Cash Flow
Sotera Health reported revenue of $1.16B for the fiscal year ended Dec 31, 2025, up 5.7% from the year before. That year, net income was $77.95M with a net margin of 6.7%, operating cash flow was $287.19M and free cash flow was $149.18M. The quarter ended Sep 30, 2026 had revenue of $324.89M and net income of $58.39M.
Revenue and Margins
The operating margin was 31.1% in the fiscal year ended Dec 2025, the highest of the 7 years shown with an operating margin. Over the 7 years to Dec 2025, revenue grew from $746.15M, a compound annual rate of 6.5%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $1.16B | +5.7% | 55.5% | 31.1% | 6.7% |
| Dec 2024 | $1.10B | +4.9% | 54.7% | 27.0% | 4.0% |
| Dec 2023 | $1.05B | N/A | 55.0% | 26.4% | 4.9% |
| Dec 2022 | $0 | -100.0% | N/A | N/A | N/A |
| Dec 2021 | $931.48M | +13.9% | 55.7% | 27.6% | 12.6% |
| Dec 2020 | $818.16M | +5.1% | 54.2% | 25.2% | -4.6% |
| Dec 2019 | $778.33M | +4.3% | 50.8% | 23.6% | -2.6% |
| Dec 2018 | $746.15M | N/A | 47.9% | 10.8% | -0.8% |
| Dec 1998 | N/A | N/A | N/A | N/A | N/A |
| Dec 1997 | N/A | N/A | N/A | N/A | N/A |
Income Statement
In the fiscal year ended Dec 2025, net income rose 75.6% from the year before. In the quarter ended Sep 2026, net income rose 20.6% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 1998 | Dec 1997 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.16B | $1.10B | $1.05B | $0 | $931.48M | $818.16M | $778.33M | $746.15M | N/A | N/A |
| Cost of revenue | $518.08M | $498.15M | $472.13M | $446.68M | $412.81M | $374.59M | $382.90M | $388.90M | N/A | N/A |
| Gross profit | $645.53M | $602.29M | $577.16M | $557.00M | $518.67M | $443.57M | $395.43M | $357.25M | N/A | N/A |
| Operating income | $362.03M | $297.63M | $276.69M | $248.35M | $256.73M | $206.02M | $183.60M | $80.85M | N/A | N/A |
| Net income | $77.95M | $44.40M | $51.38M | -$375.46M | $117.12M | -$37.49M | -$20.43M | -$5.87M | N/A | N/A |
| EBITDA | $446.83M | $473.61M | $415.88M | $405.88M | $427.65M | $375.85M | $341.99M | $314.36M | N/A | N/A |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $324.89M | $321.38M | $280.05M | $303.44M | $311.31M | $294.34M | $254.52M | $290.20M | $285.47M | $276.59M | $248.18M | $310.24M |
| Gross profit | $180.79M | $177.96M | $147.07M | $165.92M | $177.56M | $166.62M | $135.43M | $164.37M | $158.02M | $152.79M | $127.11M | $180.08M |
| Operating income | $113.64M | $106.79M | $75.83M | $170.33M | $111.18M | $88.43M | $57.04M | $87.15M | $80.51M | $76.80M | $53.17M | $104.02M |
| Net income | $58.39M | $53.64M | $26.59M | $34.85M | $48.40M | $7.96M | -$13.26M | $12.32M | $17.00M | $8.75M | $6.32M | $38.68M |
Balance Sheet
As of Dec 2025, total debt of $2.15B exceeded cash and equivalents by $1.80B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 1998 | Dec 1997 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $3.26B | $3.07B | $3.13B | $3.12B | $2.79B | $2.76B | $2.58B | $2.71B | N/A | N/A |
| Current assets | $613.41M | $526.04M | $557.24M | $645.01M | $345.96M | $315.01M | $252.35M | $312.86M | $34.43M | $40.92M |
| Cash and equivalents | $344.62M | $277.24M | $296.41M | $395.21M | $106.92M | $102.45M | $62.86M | $96.27M | N/A | N/A |
| Total liabilities | $2.66B | $2.67B | $2.69B | $2.77B | $2.20B | $2.31B | $3.22B | $2.66B | N/A | N/A |
| Short-term debt | $19.73M | $19.86M | $10.73M | $204.67M | $9.29M | $10.56M | $17.62M | $16.70M | N/A | N/A |
| Long-term debt | $2.13B | $2.21B | $2.22B | $1.75B | $1.74B | $1.82B | $2.80B | $2.19B | N/A | N/A |
| Shareholder equity | $606.03M | $404.91M | $443.73M | $350.24M | $586.10M | $452.30M | -$642.57M | $44.36M | N/A | N/A |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $3.39B | $3.31B | $3.24B | $3.26B | $3.19B | $3.22B | $3.10B | $3.07B | $3.15B | $3.06B | $3.06B | $3.13B |
| Total liabilities | $2.65B | $2.64B | $2.61B | $2.66B | $2.64B | $2.71B | $2.68B | $2.67B | $2.68B | $2.64B | $2.63B | $2.69B |
| Cash and equivalents | $412.38M | $356.72M | $314.15M | $346.46M | $299.19M | $332.44M | $304.39M | $277.24M | $306.74M | $246.08M | $261.13M | $296.41M |
| Shareholder equity | $733.24M | $665.65M | $622.50M | $606.03M | $550.47M | $511.28M | $414.09M | $404.91M | $470.16M | $422.76M | $429.39M | $443.73M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 51.9% of operating cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $287.19M | $224.16M | -$147.73M | $277.96M | $281.55M | $120.58M | $149.04M | $119.56M |
| Capital expenditures | $138.02M | $179.07M | $214.97M | $182.38M | $102.16M | $53.51M | $57.26M | $72.61M |
| Free cash flow | $149.18M | $45.09M | -$362.71M | $95.58M | $179.38M | $67.08M | $91.78M | $46.95M |
| Dividends paid | N/A | N/A | N/A | N/A | $8.42M | $0 | $691.17M | $175.84M |
| Share repurchases | N/A | N/A | N/A | N/A | N/A | $34.00M | $0 | N/A |
| Investing cash flow | -$135.14M | -$179.00M | -$214.91M | -$181.90M | -$159.83M | -$158.69M | -$57.26M | $96.64M |
| Financing cash flow | -$100.53M | -$50.56M | $265.96M | $197.76M | -$117.29M | $73.43M | -$126.03M | -$191.86M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $110.55M | $88.50M | $29.43M | $103.10M | $71.15M | $57.42M | $55.52M | $55.72M | $97.45M | $61.30M | $9.70M | $113.12M |
| Capital expenditures | $52.84M | $46.45M | $46.17M | $50.70M | $36.17M | $31.23M | $19.92M | $65.87M | $36.39M | $41.92M | $34.89M | $64.83M |
| Free cash flow | $57.71M | $42.05M | -$16.73M | $52.41M | $34.98M | $26.19M | $35.60M | -$10.15M | $61.06M | $19.37M | -$25.19M | $48.30M |
Frequently Asked Questions About SHC
What is Sotera Health's annual revenue?
Sotera Health reported revenue of $1.16B for the fiscal year ended Dec 31, 2025.
How fast is Sotera Health's revenue growing?
Revenue was up 5.7% for the fiscal year ended Dec 31, 2025 compared with the year before.
Is Sotera Health profitable?
Yes. Sotera Health reported net income of $77.95M for the fiscal year ended Dec 31, 2025, with a net margin of 6.7%.
How much free cash flow does SHC generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $287.19M minus capital expenditures of $138.02M produced free cash flow of $149.18M.
How much debt does Sotera Health have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $2.13B, short-term debt of $19.73M and cash and equivalents of $344.62M.
SHC pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors